|Articles|April 1, 2012
- Applied Clinical Trials-04-01-2012
- Volume 21
- Issue 4
Applied Clinical Trials Digital Edition - April 2012
INFORMATION TECHNOLOGY : Enhancing Risk Assessment and Mitigation REGULATORY : Sunshine Act?s Impact on the Industry Implementation of Objective Internal Monitoring Also in this issue : Impact of Transparency Policies, EMA?s Executive Director Faces Multiple Challenges, The Roles of Healthcare and Research, HIV Vaccine Trials
Advertisement
Articles in this issue
over 14 years ago
Business and News Update April 2012over 14 years ago
Transparency, Sunshine Shape Researchover 14 years ago
When Worlds Collide: Healthcare and Researchover 14 years ago
CRO Founded to Address Neglected Diseases in Under Served Countriesover 14 years ago
EFGCP Acts to Reduce Ethics Problemsover 14 years ago
Sunshine Act's Impactover 14 years ago
Keeping a Cool Head Amidst Turmoilover 14 years ago
Startup Offers New Take on Recruitmentover 14 years ago
Risk Assessment and MitigationAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5